A. Mühlbäck

Identification of two compound heterozygous VPS13A large deletions in chorea‐acanthocytosis only by protein and quantitative DNA analysis

J. Slotta-Huspenina, A. Danek, B. Haslinger, 2020, Molecular genetics & genomic medicine.

H54 Psychosocial impact of Huntington’s disease and incentives to improve care for affected families in an underserved region of the slovak republic

J. Bušková, J. Benetin, A. Mühlbäck, 2022, H: Clinical care and clinical services.

Validation Study of a German Cognitive Battery for Huntington’s Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden

J. Klempír, O. Bezdicek, G. Landwehrmeyer, 2020, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Quality of life, health-related quality of life, and associated factors in Huntington’s disease: a systematic review

N. Chavannes, R. Moldovan, J. Roth, 2023, Journal of Neurology.

Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design Approach

N. Chavannes, J. Klempír, N. Vegt, 2021, Frontiers in Neurology.

Establishing normative data for the evaluation of cognitive performance in Huntington's disease considering the impact of gender, age, language, and education.

K. Lindenberg, J. Klempír, O. Bezdicek, 2023, Journal of neurology.

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease

R. Blumenstein, C. Sampaio, S. Noble, 2021, Frontiers in Neurology.

Speech biomarkers in Huntington's disease: A cross‐sectional study in pre‐symptomatic, prodromal and early manifest stages

K. Lindenberg, J. Rusz, T. Tykalová, 2023, European Journal of Neurology.